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Standardised patients (SPs)—also called 
patient actors, simulated patients or mystery 
clients—have a long history in medical educa-
tion in high-income countries.1–5 They are 
now increasingly being used in low-income 
and middle-income countries (LMICs) to 
measure quality of care in a variety of clinical 
and retail (drug shop/pharmacy) settings. 
SPs are healthy people, or people with stable 
conditions, extensively trained to consistently 
simulate the medical history, physical symp-
toms and emotional characteristics of a real 
patient to multiple healthcare providers, and 
subsequently to report details of those inter-
actions. The SP approach has been referred 
to as the ‘gold standard’ for capturing 
actual provider behaviour in the healthcare 
setting.6 7
In a paper published in BMJ Global Health, 
Kwan et al discussed the different types of 
research questions that can be addressed 
using SPs, and the various methodological 
and analytical issues to consider.8 In a recent 
complementary paper, King et al provide a step-
by-step ‘how to’ guide for planning and imple-
menting an SP study.9 The two papers, and 
the detailed field manual provided by Kwan et 
al in their appendix, combine to make a valu-
able set of resources for researchers using the 
SP method. In this commentary, members of 
the Standardised Patients Working Group, 
comprising economists, epidemiologists and 
social scientists across nine universities and 
global health institutions, elaborate on five 
key methodological and ethical issues raised in 
the two papers, and discuss how these can be 
assessed.
SimulaTion
A key concern about SPs is that they are not 
real patients and therefore provider responses 
to SPs may not be valid. Researchers using this 
method in LMICs go to considerable effort 
to train SPs to act as real patients. SPs receive 
coaching to build their understanding of the 
background story and presentation, including 
the body language of ill individuals10—see the 
online supplementary appendix to the Kwan 
et al paper for examples of this process. Many 
studies also recruit SPs from the local commu-
nities where they are sent, as accents, language 
or other cultural characteristics are not easily 
replicated.11
Despite these efforts, concerns are often 
raised that providers may suspect that SPs are 
not genuine patients or carers. To allay these 
concerns, carefully designed studies include 
detection surveys where providers are contacted 
after an SP survey has been completed and 
asked about any suspected ‘fake’ patients (e.g. 
their symptoms, gender, age). In most studies, 
5% or fewer of SPs are correctly suspected by 
providers of being ‘fake’ patients.9
TypeS of CliniCal CondiTionS
An important challenge with SPs is the scope 
of conditions that can be investigated. The 
SP method is only feasible for conditions that 
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do not require physiological symptoms to be evident or 
invasive examinations to be performed: family planning 
request, cold, diarrhoea, tuberculosis or angina are exam-
ples of cases popular in SP studies in LMICs.9 However, 
the spread of mhealth technology may allow SPs to show 
providers ‘faked’ results on a mobile phone, and there-
fore, allow for an expansion of SP cases.12
Another challenge is that SPs do not typically complete 
follow-up visits,13 which excludes the assessment of conti-
nuity of care or chronic disease management. Studies 
from high-income countries highlight a ‘first visit bias’ 
that can skew assessment of quality.14 15 A study in the 
USA found that quality of care for gastritis and hip pain 
was higher in two successive consultations compared with 
the first one, leading the authors to conclude that quality 
of care is underestimated when only the first visit is 
considered, and that SPs are more appropriate for cases 
requiring ‘definitive clinical action’ at the first visit.16 
While there are clear limits around the types of condi-
tions that are suitable for SPs, the method has produced 
accurate measurements of the quality of care across a 
reasonably broad range of single encounters in LMIC 
settings.17 That being said, there is a need, to find ways 
to extend the SP method for multiple, sequential visits to 
the same provider for chronic conditions.8 9
ReCall
One of the reasons behind the growing enthusiasm for 
SPs in LMICs is the wealth of data that this approach 
can help collect. SPs are typically asked to complete a 
structured questionnaire or checklist shortly after their 
consultation, capturing details of their interaction with 
the provider including: how long did the consultation 
last? Which questions did the provider ask? Which phys-
ical examinations did they do? What advice did they give? 
Which treatment did they choose? All of this information 
is invaluable in settings where electronic medical records 
rarely exist and paper-based patient files contain minimal 
information. SPs are partly chosen on their ability to 
accurately memorise clinical interactions, are carefully 
trained to do this and have been found to be much better 
at remembering the consultation than actual patients.18 19
One approach to empirically assessing the accuracy 
of SP recall involves covert audio recording of the clin-
ical interaction and comparing this with the SP’s report. 
Concealed recorders have been successfully used in one 
study in India which showed high quality recall by SPs.17 
However, the use of covert recording raises ethical issues 
and is limited to verbal communication. Another possible 
approach is for SPs to be accompanied by another field-
worker acting as a family member or friend, and to ask 
both individuals to answer independently the recall ques-
tions in order to measure inter-rater agreement.
STandaRdiSaTion
When comparing different types of providers, the SP 
approach can ensure comparability without concerns 
of patient selection issues, such as differences in patient 
socioeconomic characteristics (e.g., poorer patients more 
likely to consult public providers than private providers) 
or health status (e.g., sicker patients consulting more 
reputed providers). Standardisation allows researchers 
to alter one component of the patient–provider inter-
action at a time in order to estimate the causal impact 
of that component (e.g., estimating whether patient 
ethnicity has an impact on quality of care as investigated 
by Planas et al).20 This ability to experiment with patient 
characteristics or attitudes is a key strength of the SP 
approach but researchers should also be alert to varia-
tions in the performance by SPs. Variation could arise 
if different individuals portray the same SP case in a 
different way, or if the same SP case is portrayed differ-
ently over time.
Measuring the consistency of SPs’ portrayal of cases 
is done during training and sometimes during piloting 
(where SPs can be observed by a supervisor pretending to 
be a relative or friend), but it is more challenging during 
fieldwork. SP consistency can be measured indirectly by 
having multiple individuals portray the same medical 
case at the same healthcare provider. For instance, 
in their 2018 study using SPs to evaluate the quality 
of tuberculosis care in India, Kwan et al21 found that 
providers delivered relatively consistent care, repeating 
all observed actions, including mistakes, approximately 
75% of the time. Further examination of the same dataset 
showed that almost none of the variation in outcomes 
was predicted by personal SP characteristics such as age, 
gender, height and weight, suggesting that SP portrayals 
were sufficiently standardised.6
infoRmed ConSenT
A major ethical concern surrounding SPs is the decep-
tion of healthcare providers and whether or not informed 
consent should be sought from them. Since the objective 
of SP studies is to understand the unfettered interaction 
between provider and client, it has been widely recognised 
that seeking informed consent from a provider can jeop-
ardise the scientific validity of the study by influencing 
the decision of providers to take part (creating selection 
bias) or influencing their behaviour (Hawthorne effect) 
if they think SP visits are imminent.22 23
King et al9 discuss possible approaches to provider 
consent, such as obtaining consent well in advance to 
minimise Hawthorne effects, seeking consent from 
overarching authorities to minimise selection bias or 
obtaining a waiver of consent. Waivers of consent have 
been granted for minimally intrusive research in commu-
nity pharmacies and other drug outlets19 24 as well as a few 
large studies with providers.6 21 Since results are reported 
at the aggregate level, the benefits of SP studies including 
the provision of objective data on quality of care must be 
balanced against risks posed to individual providers and 
facilities.
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ConCluSion
In summary, we would urge more research teams to 
report on the challenges and opportunities raised in this 
commentary. This information will enhance the uptake 
and generalisability of evidence from SP surveys and in 
turn, strengthen quality of care measurement in LMIC. 
Future investment in high-quality, accountable health 
systems relies on such information.
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